In the first quarter (Q1) of 2020, the COVID-19 virus outbreak made Indonesia face challenges to increase economic growth. Under these conditions, pharmaceutical firm Kalbe Farma (KLBF) posted net sales of Rp5.79 trillion for Q1 this year, growing 8% from Rp5.36 trillion in the corresponding period of 2019.
To subscribe please click here
